Get started
Author

Jan Harder

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 · Anja Rinke, Hans-Helge Müller, et al. · Journal of Clinical Oncology · 2,508
Phase I Clinical Study of AZD2171, an Oral Vascular Endothelial Growth Factor Signaling Inhibitor, in Patients With Advanced Solid Tumors
2007 · Joachim Drevs, Patrizia Siegert, et al. · Journal of Clinical Oncology · 303
Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
2012 · J Harder, G Ihorst, et al. · British Journal of Cancer · 188
PDF
EGFR and HER2 expression in advanced biliary tract cancer
2009 · Jan Harder, Oliver Waiz, et al. · World Journal of Gastroenterology · 124
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
2006 · J Harder, B Riecken, et al. · British Journal of Cancer · 123
PDF
Treatment of unresectable cholangiocarcinoma
2012 · Jan B. Kuhlmann, Wulf Euringer, et al. · European Journal of Gastroenterology & Hepatology · 122
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study
2009 · F Kullmann, S Hollerbach, et al. · British Journal of Cancer · 91
PDF
Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients
2011 · W Kreisel, M Dahlberg, et al. · Bone Marrow Transplantation · 89
PDF
Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy
2012 · Matthias Breidert, Richard Fischer, et al. · Saudi Journal of Gastroenterology · 81
Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver
2008 · Jan Harder, Oliver G. Opitz, et al. · International Journal of Cancer · 58
Stereotactic fractionated radiotherapy for Klatskin tumours
2010 · Felix Momm, Eva Schubert, et al. · Radiotherapy and Oncology · 48
KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy
2011 · F. Kullmann, A. Hartmann, et al. · Oncology · 46
PDF
EGFR overexpression induces activation of telomerase via PI3K/AKT‐mediated phosphorylation and transcriptional regulation through Hif1‐alpha in a cellular model of oral–esophageal carcinogenesis
2010 · Steffen Heeg, Nina Hirt, et al. · Cancer Science · 46
PDF
Prognostic Relevance of Carbohydrate Antigen 19-9 Levels in Patients with Advanced Biliary Tract Cancer
2007 · Jan Harder, Oliver Kummer, et al. · Cancer Epidemiology Biomarkers & Prevention · 44
A Novel Thymoma-Associated Immunodeficiency with Increased Naive T Cells and Reduced CD247 Expression
2015 · Petros Christopoulos, Elaine P Dopfer, et al. · The Journal of Immunology · 37
CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients
2009 · J Harder, V Engelstaedter, et al. · British Journal of Cancer · 24
PDF
A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer
2009 · Andre Mihaljevic, Peter Büchler, et al. · BMC Surgery · 18
PDF
Hepatitis C virus infection in intravenous drug users
2004 · J. Harder, E. Walter, et al. · Clinical Microbiology and Infection · 17
3533 POSTER Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in 1st line metastatic pancreatic cancer–amulticenter phase II study
2007 · F. Kullmann, S. Hollerbach, et al. · European Journal of Cancer Supplements · 14
Treatment of Renal Cell Carcinomaassociated Dermatomyositis with Renal Arterial Embolization and Percutaneous Radiofrequency Heat Ablation
2004 · Oliver Schaefer, Christian Lohrmann, et al. · Journal of Vascular and Interventional Radiology · 14
PDF
Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients
2014 · Verena Kirn, Rong Shi, et al. · Journal of Cancer Research and Clinical Oncology · 11
EGFR and HER2 Expression in advanced Biliary Tract Cancer
2008 · J Harder, O Waiz, et al. · Zeitschrift für Gastroenterologie · 6
Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization
2008 · Felix Flohr, Jan Harder, et al. · Hepatology · 6
Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer
2013 · Jan Harder · World Journal of Gastroenterology · 5
PDF
Trastuzumab and capecitabine in patients with HER2-expressing metastatic pancreatic cancer: A multicenter phase II study of the German AIO Pancreatic Cancer Group (AIO PK-0204).
2010 · M. Geissler, R. Hofheinz, et al. · Journal of Clinical Oncology · 3
Works count: 50
Citation count: 4,035
H-index: 17
I10-index: 21
Year
Topic
Type